Ginkgo Bioworks Holdings, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Ginkgo Bioworks Holdings, Inc. (DNA) is 974.12M

According to Ginkgo Bioworks Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 974.12M. This represents a change of 13.82% compared to the average of 855.84M of the last 4 quarters.

Ginkgo Bioworks Holdings, Inc. (DNA) Historical Enterprise Value (quarterly & annually)

How has DNA Enterprise Value performed in the past?

The mean historical Enterprise Value of Ginkgo Bioworks Holdings, Inc. over the last ten years is 5.53B. The current 974.12M Enterprise Value has changed -82.39% with respect to the historical average. Over the past ten years (40 quarters), DNA's Enterprise Value was at its highest in in the September 2021 quarter at 13.62B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Ginkgo Bioworks Holdings, Inc. (DNA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ginkgo Bioworks Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ginkgo Bioworks Holdings, Inc. (DNA) Average Enterprise Value

How has DNA Enterprise Value performed in the past?

The current Enterprise Value of Ginkgo Bioworks Holdings, Inc. (DNA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Ginkgo Bioworks Holdings, Inc. (DNA) Enterprise Value vs. Peers

How is DNA’s Enterprise Value compared to its peers?

Ginkgo Bioworks Holdings, Inc.’s Enterprise Value is less than Iovance Biotherapeutics, Inc. (3.49B), less than Replimune Group, Inc. (1.54B), less than MBX Biosciences, Inc. Common Stock (2.58B), greater than MeiraGTx Holdings plc (862.81M), greater than ArriVent BioPharma, Inc. (533.64M), less than Maravai LifeSciences Holdings, Inc. (4.17B), greater than Astria Therapeutics, Inc. (626.31M), less than Vir Biotechnology, Inc. (1.69B), greater than Arvinas, Inc. (394.85M), greater than Valneva SE (540.63M),

Build a custom stock screener for Ginkgo Bioworks Holdings, Inc. (DNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ginkgo Bioworks Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ginkgo Bioworks Holdings, Inc. (DNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ginkgo Bioworks Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.